Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$115.41

-3.08 (-2.60%)

08:07
10/19/16
10/19
08:07
10/19/16
08:07

Johnson & Johnson has potential upside from expanding pipeline, says UBS

UBS analyst Matt Miksic noted Johnson & Johnson delivered a solid quarter and said he believes there is upside to his Buy thesis. The analyst cited the company's expanding pipeline, capital allocation strategy, and contracting across its broad portfolio and patient assistance programs is expected to help mitigate pressure from biosimilar competition. Miksic reiterated his Buy rating and raised his price target to $144 from $137 on Johnson & Johnson shares.

  • 27

    Oct

  • 06

    Nov

JNJ Johnson & Johnson
$115.41

-3.08 (-2.60%)

09/19/16
LEER
09/19/16
NO CHANGE
LEER
Abbott, Johnson & Johnson transaction positive for both companies, says Leerink
Leerink analyst Danielle Antalffy says the sale of Abbott's (ABT) Medical Optics ophthalmology business to Johnson & Johnson (JNJ) is positive for both companies. The deal strengthens Abbott's balance sheet and eliminates the need for a previously expected $3B capital raise, and adds a key component to Johnson & Johnson's already-strong vision care franchise, the analyst notes.
10/07/16
RBCM
10/07/16
NO CHANGE
RBCM
Johnson & Johnson weakness creates buying opportunity, says RBC Capital
RBC Capital analyst Glenn Novarro says that Johnson & Johnson underperformed the market in Q3 due to a number of factors including Remicade biosimilar risk and the pharma pricing debate. The analyst says that "these concerns are manageable/overblown," and he expects the company to report strong Q3 results, driven by a strong pharma performance. Novoroo expects the company's Q3 revenue to come in slightly above expectations, and he predicts that the company will narrow its 2016 EPS guidance to the high end of the previous range. The analyst recommends buying the stock. He keeps a $133 price target and Outperform rating on the shares.
10/18/16
UBSW
10/18/16
NO CHANGE
Target $137
UBSW
Buy
Johnson & Johnson robust pipeline underappreciated, says UBS
UBS analyst Matt Miksic said the Johnson & Johnson pipeline remains robust and is underappreciated. The analyst said the recent launch of biosimilars removes uncertainty and should be positive for the stock. He also expects the additional deployment of the company's capital - to expand its pipeline through in-licensing, partnerships or mid-sized acquisitions - to be incremental to his Buy thesis. Miksic has a $137 price target on Johnson & Johnson shares.
10/19/16
LEER
10/19/16
NO CHANGE
Target $140
LEER
Outperform
Johnson & Johnson should be bought on weakness, says Leerink
Leerink analyst Danielle Antalffy believes the recent selloff in Johnson & Johnson's shares was overdone and would recommend buying on weakness. The analyst views the company as well-equipped to manage the inevitable Remicade headwind and continues to believe Johnson & Johnson can drive improving top-line growth in 2017. She reiterates an Outperform rating and $140 price target on the shares.

TODAY'S FREE FLY STORIES

AAL

American Airlines

$45.31

-0.69 (-1.50%)

11:25
09/19/17
09/19
11:25
09/19/17
11:25
Options
American Airlines call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

HQY

HealthEquity

$45.77

0.65 (1.44%)

11:25
09/19/17
09/19
11:25
09/19/17
11:25
Conference/Events
HealthEquity participates in a conference call with Chardan »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

NHI

National Health Investors

$79.82

-0.175 (-0.22%)

11:25
09/19/17
09/19
11:25
09/19/17
11:25
Conference/Events
National Health Investors to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

OPXA

Opexa Therapeutics

$1.09

0.07 (6.86%)

11:25
09/19/17
09/19
11:25
09/19/17
11:25
Conference/Events
Opexa Therapeutics to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

JKS

JinkoSolar

$27.78

0.14 (0.51%)

, JASO

JA Solar

$8.14

0.25 (3.17%)

11:21
09/19/17
09/19
11:21
09/19/17
11:21
Periodicals
EU eases trade restrictions on Chinese solar panels, People's Daily reports »

China has welcomed the…

JKS

JinkoSolar

$27.78

0.14 (0.51%)

JASO

JA Solar

$8.14

0.25 (3.17%)

CSIQ

Canadian Solar

$16.80

-0.47 (-2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUVA

NuVasive

$57.80

-0.68 (-1.16%)

, EFII

Electronics for Imaging

$41.56

-0.03 (-0.07%)

11:21
09/19/17
09/19
11:21
09/19/17
11:21
Hot Stocks
NuVasive slides as GlassHouse Research sees 'profusion of accounting red flags' »

GlassHouse Research noted…

NUVA

NuVasive

$57.80

-0.68 (-1.16%)

EFII

Electronics for Imaging

$41.56

-0.03 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

$NSD

NASDAQ Market Internals

11:17
09/19/17
09/19
11:17
09/19/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIR

AAR Corp.

$36.87

0.32 (0.88%)

11:16
09/19/17
09/19
11:16
09/19/17
11:16
Hot Stocks
AAR Corp. to acquire two MRO facilities from Premier Aviation »

AAR announced that it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

$NYE

NYSE Market Internals

11:16
09/19/17
09/19
11:16
09/19/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
09/19/17
09/19
11:15
09/19/17
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

BBY

Best Buy

$52.43

-4.92 (-8.58%)

11:13
09/19/17
09/19
11:13
09/19/17
11:13
Technical Analysis
Technical View: Best Buy falls to session lows following outlook »

The shares have been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

SIEGY

Siemens

$69.98

0.26 (0.37%)

11:11
09/19/17
09/19
11:11
09/19/17
11:11
Hot Stocks
Siemens, PAS announce partnership to provide monitoring for control systems »

Siemens and PAS Global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$58.51

0.395 (0.68%)

11:10
09/19/17
09/19
11:10
09/19/17
11:10
Options
Repeat of bullish option activity in UAL »

Repeat of bullish option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

VIAB

Viacom

$27.32

-0.35 (-1.26%)

, DISCA

Discovery

$21.32

-0.62 (-2.83%)

11:08
09/19/17
09/19
11:08
09/19/17
11:08
Hot Stocks
Cowen sees more trouble ahead for traditional TV names »

Research firm Cowen cut…

VIAB

Viacom

$27.32

-0.35 (-1.26%)

DISCA

Discovery

$21.32

-0.62 (-2.83%)

FOXA

21st Century Fox

$26.50

-0.55 (-2.03%)

DIS

Disney

$98.43

0.325 (0.33%)

CBS

CBS

$57.71

-0.01 (-0.02%)

GOOGL

Alphabet Class A

$929.75

-5.54 (-0.59%)

GOOG

Alphabet

$915.00

-5.29 (-0.57%)

FB

Facebook

$170.01

-1.63 (-0.95%)

NFLX

Netflix

$184.62

2.27 (1.24%)

AMZN

Amazon.com

$974.19

-12.6 (-1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

  • 02

    Oct

  • 16

    Oct

  • 29

    Nov

XON

Intrexon

$19.19

-0.28 (-1.44%)

11:07
09/19/17
09/19
11:07
09/19/17
11:07
Hot Stocks
Intrexon's Oxitec plans to build centralized mosquito egg production unit »

Oxitec, a wholly owned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRCM

Care.com

$14.45

-0.14 (-0.96%)

11:04
09/19/17
09/19
11:04
09/19/17
11:04
Hot Stocks
Care.com names George Bell to board as lead independent director »

Care.com yesterday…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTB

M&T Bank

$152.67

1 (0.66%)

11:03
09/19/17
09/19
11:03
09/19/17
11:03
Hot Stocks
M&T Bank enters community-focused strategic partnership with NY Jets »

The New York Jets and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$88.33

-6.25 (-6.61%)

11:02
09/19/17
09/19
11:02
09/19/17
11:02
Hot Stocks
Coordinated Care awarded Commendable Accreditation status from NCQA »

Coordinated Care, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

USB

U.S. Bancorp

$52.64

0.255 (0.49%)

11:01
09/19/17
09/19
11:01
09/19/17
11:01
Hot Stocks
U.S. Bancorp boosts quarterly dividend by 7% to 30c »

U.S. Bancorp said its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 17

    Jan

NUVA

NuVasive

$57.80

-0.68 (-1.16%)

11:01
09/19/17
09/19
11:01
09/19/17
11:01
Periodicals
NuVasive mentioned cautiously in short report from GlassHouse Research 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RGC

Regal Entertainment

$16.08

-0.365 (-2.22%)

11:00
09/19/17
09/19
11:00
09/19/17
11:00
Conference/Events
Regal Entertainment management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Sep

  • 02

    Oct

T

AT&T

$37.94

0.515 (1.38%)

11:00
09/19/17
09/19
11:00
09/19/17
11:00
Options
AT&T option volume double normal as implied volatility term structure inverts »

AT&T option volume…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

KR

Kroger

$21.32

-0.12 (-0.56%)

10:59
09/19/17
09/19
10:59
09/19/17
10:59
Hot Stocks
Kroger outlook revised to Negative from Stable by Fitch »

Fitch affirmed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

  • 30

    Nov

TSLA

Tesla

$385.00

5.19 (1.37%)

10:58
09/19/17
09/19
10:58
09/19/17
10:58
Conference/Events
Tesla management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 02

    Oct

WK

Workiva

$19.75

-0.15 (-0.75%)

10:55
09/19/17
09/19
10:55
09/19/17
10:55
Conference/Events
Workiva to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.